Annual FCF
-$96.71 M
+$15.50 M+13.81%
September 30, 2024
Summary
- As of February 8, 2025, ENTA annual free cash flow is -$96.71 million, with the most recent change of +$15.50 million (+13.81%) on September 30, 2024.
- During the last 3 years, ENTA annual FCF has fallen by -$25.97 million (-36.70%).
- ENTA annual FCF is now -230.10% below its all-time high of $74.34 million, reached on September 30, 2015.
Performance
ENTA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$19.35 M
+$1.97 M+9.22%
September 30, 2024
Summary
- As of February 8, 2025, ENTA quarterly free cash flow is -$19.35 million, with the most recent change of +$1.97 million (+9.22%) on September 30, 2024.
- Over the past year, ENTA quarterly FCF has increased by +$3.62 million (+15.76%).
- ENTA quarterly FCF is now -119.59% below its all-time high of $98.76 million, reached on March 31, 2015.
Performance
ENTA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$96.71 M
+$3.62 M+3.61%
September 30, 2024
Summary
- As of February 8, 2025, ENTA TTM free cash flow is -$96.71 million, with the most recent change of +$3.62 million (+3.61%) on September 30, 2024.
- Over the past year, ENTA TTM FCF has increased by +$15.50 million (+13.81%).
- ENTA TTM FCF is now -179.13% below its all-time high of $122.21 million, reached on March 31, 2015.
Performance
ENTA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ENTA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.8% | +15.8% | +13.8% |
| 3 y3 years | -36.7% | +8.1% | -36.7% |
| 5 y5 years | -246.5% | +8.1% | -36.7% |
ENTA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -36.7% | +13.8% | -41.9% | +50.1% | -39.5% | +14.6% |
| 5 y | 5-year | -246.5% | +13.8% | -235.1% | +50.1% | -301.5% | +14.6% |
| alltime | all time | -230.1% | +13.8% | -119.6% | +50.1% | -179.1% | +14.6% |
Enanta Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$96.71 M(-13.8%) | -$19.35 M(-9.2%) | -$96.71 M(-3.6%) |
| Jun 2024 | - | -$21.32 M(-29.6%) | -$100.33 M(-11.4%) |
| Mar 2024 | - | -$30.27 M(+17.4%) | -$113.29 M(+14.2%) |
| Dec 2023 | - | -$25.77 M(+12.2%) | -$99.19 M(-11.6%) |
| Sep 2023 | -$112.21 M(+29.1%) | -$22.97 M(-33.0%) | -$112.21 M(+5.6%) |
| Jun 2023 | - | -$34.28 M(+112.0%) | -$106.21 M(+4.3%) |
| Mar 2023 | - | -$16.17 M(-58.3%) | -$101.79 M(-9.2%) |
| Dec 2022 | - | -$38.80 M(+128.6%) | -$112.07 M(+29.0%) |
| Sep 2022 | -$86.91 M(+22.8%) | -$16.97 M(-43.2%) | -$86.91 M(-4.5%) |
| Jun 2022 | - | -$29.85 M(+12.9%) | -$90.99 M(-0.1%) |
| Mar 2022 | - | -$26.45 M(+94.0%) | -$91.04 M(+31.4%) |
| Dec 2021 | - | -$13.63 M(-35.2%) | -$69.30 M(-2.0%) |
| Sep 2021 | -$70.75 M(-1353.7%) | -$21.05 M(-29.6%) | -$70.75 M(+8.0%) |
| Jun 2021 | - | -$29.91 M(+535.1%) | -$65.48 M(+62.3%) |
| Mar 2021 | - | -$4.71 M(-68.8%) | -$40.34 M(+89.3%) |
| Dec 2020 | - | -$15.08 M(-4.5%) | -$21.31 M(-477.6%) |
| Sep 2020 | $5.64 M(-91.5%) | -$15.79 M(+231.7%) | $5.64 M(-81.0%) |
| Jun 2020 | - | -$4.76 M(-133.2%) | $29.68 M(-14.6%) |
| Mar 2020 | - | $14.32 M(+20.6%) | $34.75 M(-27.6%) |
| Dec 2019 | - | $11.88 M(+44.0%) | $48.01 M(-27.3%) |
| Sep 2019 | $66.00 M(+151.5%) | $8.25 M(+2622.4%) | $66.00 M(-22.8%) |
| Jun 2019 | - | $303.00 K(-98.9%) | $85.47 M(-3.0%) |
| Mar 2019 | - | $27.58 M(-7.7%) | $88.11 M(+68.8%) |
| Dec 2018 | - | $29.87 M(+7.8%) | $52.20 M(+99.0%) |
| Sep 2018 | $26.24 M | $27.72 M(+840.9%) | $26.24 M(-52.8%) |
| Jun 2018 | - | $2.95 M(-135.4%) | $55.59 M(+18.0%) |
| Mar 2018 | - | -$8.33 M(-313.3%) | $47.11 M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $3.90 M(-93.2%) | $51.86 M(+3.4%) |
| Sep 2017 | $50.15 M(+61.4%) | $57.07 M(-1130.7%) | $50.15 M(-629.8%) |
| Jun 2017 | - | -$5.54 M(+54.7%) | -$9.47 M(+42.3%) |
| Mar 2017 | - | -$3.58 M(-263.3%) | -$6.65 M(-221.7%) |
| Dec 2016 | - | $2.19 M(-186.3%) | $5.47 M(-82.4%) |
| Sep 2016 | $31.07 M(-58.2%) | -$2.54 M(-6.8%) | $31.07 M(+4.8%) |
| Jun 2016 | - | -$2.73 M(-131.9%) | $29.66 M(+66.8%) |
| Mar 2016 | - | $8.54 M(-69.3%) | $17.78 M(-83.5%) |
| Dec 2015 | - | $27.80 M(-802.8%) | $108.00 M(+45.3%) |
| Sep 2015 | $74.34 M(+288.2%) | -$3.96 M(-72.9%) | $74.34 M(+2.0%) |
| Jun 2015 | - | -$14.60 M(-114.8%) | $72.88 M(-40.4%) |
| Mar 2015 | - | $98.76 M(-1783.6%) | $122.21 M(+537.2%) |
| Dec 2014 | - | -$5.87 M(+8.3%) | $19.18 M(+0.2%) |
| Sep 2014 | $19.15 M(+90.6%) | -$5.42 M(-115.6%) | $19.15 M(-12.4%) |
| Jun 2014 | - | $34.73 M(-913.3%) | $21.86 M(-216.0%) |
| Mar 2014 | - | -$4.27 M(-27.5%) | -$18.84 M(+286.0%) |
| Dec 2013 | - | -$5.89 M(+117.9%) | -$4.88 M(-148.6%) |
| Sep 2013 | $10.05 M(-55.1%) | -$2.71 M(-54.7%) | $10.05 M(-8.2%) |
| Jun 2013 | - | -$5.97 M(-161.6%) | $10.94 M(-16.1%) |
| Mar 2013 | - | $9.69 M(+7.3%) | $13.04 M(-62.3%) |
| Dec 2012 | - | $9.03 M(-598.3%) | $34.62 M(+54.8%) |
| Sep 2012 | $22.37 M(-5.1%) | -$1.81 M(-53.2%) | $22.37 M(-7.5%) |
| Jun 2012 | - | -$3.88 M(-112.4%) | $24.18 M(-13.8%) |
| Mar 2012 | - | $31.27 M(-1072.5%) | $28.06 M(-972.5%) |
| Dec 2011 | - | -$3.22 M | -$3.22 M |
| Sep 2011 | $23.57 M(-330.8%) | - | - |
| Sep 2010 | -$10.21 M | - | - |
FAQ
- What is Enanta Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals annual FCF year-on-year change?
- What is Enanta Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals quarterly FCF year-on-year change?
- What is Enanta Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Enanta Pharmaceuticals?
- What is Enanta Pharmaceuticals TTM FCF year-on-year change?
What is Enanta Pharmaceuticals annual free cash flow?
The current annual FCF of ENTA is -$96.71 M
What is the all time high annual FCF for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high annual free cash flow is $74.34 M
What is Enanta Pharmaceuticals annual FCF year-on-year change?
Over the past year, ENTA annual free cash flow has changed by +$15.50 M (+13.81%)
What is Enanta Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of ENTA is -$19.35 M
What is the all time high quarterly FCF for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high quarterly free cash flow is $98.76 M
What is Enanta Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, ENTA quarterly free cash flow has changed by +$3.62 M (+15.76%)
What is Enanta Pharmaceuticals TTM free cash flow?
The current TTM FCF of ENTA is -$96.71 M
What is the all time high TTM FCF for Enanta Pharmaceuticals?
Enanta Pharmaceuticals all-time high TTM free cash flow is $122.21 M
What is Enanta Pharmaceuticals TTM FCF year-on-year change?
Over the past year, ENTA TTM free cash flow has changed by +$15.50 M (+13.81%)